The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations between baseline body composition and cancer-specific mortality following neoadjuvant chemotherapy and radical cystectomy for bladder cancer.
 
Leonidas Nikolaos Diamantopoulos
No Relationships to Disclose
 
Steven Ngo
No Relationships to Disclose
 
Reno Maldonado
No Relationships to Disclose
 
Ryan Blair O'Malley
Research Funding - GE Healthcare
 
Grace Laidlaw
No Relationships to Disclose
 
Florian J. Fintelmann
Consulting or Advisory Role - Jounce Therapeutics
Research Funding - BTG (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending related to body composition analysis; Royalties from writing a book with Elsevier (publisher)
 
Sarah K Holt
No Relationships to Disclose
 
John L. Gore
Research Funding - Ferring
 
George R. Schade
Patents, Royalties, Other Intellectual Property - Global Cancer Technology
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Dendreon
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Magforce; MDxHealth (Inst)
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Exelixis; Foundation Medicine; Genzyme; GlaxoSmithKline; HERON; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Roche; Seagen
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Immunomedics (Inst); Pfizer (Inst)
 
Robert B. Montgomery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Andrew Caleb Hsieh
Honoraria - Hotspot Therapeutics
Research Funding - eFFECTOR Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
Heather H. Cheng
Research Funding - Astellas Medivation (Inst); Clovis Oncology (Inst); Color Genomics Foundation (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Sanofi (Inst)
 
Todd Yezefski
No Relationships to Disclose
 
Michael Thomas Schweizer
Consulting or Advisory Role - Janssen
Research Funding - AstraZeneca (Inst); Immunomedics (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)
 
Evan Y. Yu
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Incyte; Janssen; Merck; Pharmacyclics; QED Therapeutics; Seagen
Research Funding - Daiichi Sankyo (Inst); Dendreon (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Jonathan L. Wright
Speakers' Bureau - Foundation Health Partners J. Michael Carroll Cancer Center; OncLive; seattle cancer care alliance
Research Funding - Altor BioScience; Merck; Nucleix
Other Relationship - Movember Foundation; UpToDate
 
Sarah P. Psutka
Honoraria - Prime Education
Consulting or Advisory Role - Nucleix
Travel, Accommodations, Expenses - Prime Education